309 related articles for article (PubMed ID: 17430078)
1. Update on HDFN: new information on long-standing controversies.
Eder AF
Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
[TBL] [Abstract][Full Text] [Related]
2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
4. Red Blood Cell Alloimmunization in the Pregnant Patient.
Webb J; Delaney M
Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
[TBL] [Abstract][Full Text] [Related]
5. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
6. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
[TBL] [Abstract][Full Text] [Related]
7. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D
BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
[TBL] [Abstract][Full Text] [Related]
9. Haemolytic disease of the fetus and newborn.
de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
[TBL] [Abstract][Full Text] [Related]
10. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
Trevett TN; Moise KJ
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
[TBL] [Abstract][Full Text] [Related]
11. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
12. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
13. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
[TBL] [Abstract][Full Text] [Related]
14. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive approach for the management of hemolytic disease of the fetus.
Illanes S; Soothill P
Expert Rev Hematol; 2009 Oct; 2(5):577-82. PubMed ID: 21083022
[TBL] [Abstract][Full Text] [Related]
17. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
18. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
Lenkiewicz B; Zupańska B
Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
[TBL] [Abstract][Full Text] [Related]
19. Case report: moderate hemolytic disease of the newborn due to anti-G.
Huber AR; Leonard GT; Driggers RW; Learn SB; Gilstad CW
Immunohematology; 2006; 22(4):166-70. PubMed ID: 17430075
[TBL] [Abstract][Full Text] [Related]
20. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
Kulinska R
Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]